Patient | Mean tumor dose (Gy/GBq) | Kidney dose (Gy/GBq) | Stomach dose (Gy/GBq) | Bone marrow dose (Gy/GBq) | ||||
---|---|---|---|---|---|---|---|---|
Entresto® | Without | With | Without | With | Without | With | Without | With |
1 | n.a | n.a | 0.04 | 0.07 | 0.3 | 0.48 | 0.02 | 0.02 |
2 | n.a | n.a | 0.05 | 0.13 | 0.26 | 0.43 | 0.04 | 0.04 |
3 | n.a | n.a | 0.05 | 0.12 | 0.03 | 0.05 | 0.03 | 0.04 |
4 | 0.03 | 0.05 | 0.05 | 0.12 | 0.23 | 0.50 | 0.03 | 0.05 |
4a | 0.05 | 0.07 | 0.05 | 0.12 | 0.23 | 0.50 | 0.03 | 0.05 |
5 | n.a | n.a | 0.03 | 0.07 | 1.15 | 1.53 | 0.02 | 0.03 |
6 | 0.99 | 1.26 | 0.05 | 0.11 | 0.19 | 0.30 | 0.04 | 0.06 |
7 | 0.22 | 0.75 | 0.04 | 0.10 | 0.17 | 0.88 | 0.03 | 0.04 |
7a | 0.47 | 1.12 | 0.04 | 0.10 | 0.17 | 0.88 | 0.03 | 0.04 |
8 | 0.33 | 0.73 | 0.03 | 0.09 | 0.2 | 0.39 | 0.03 | 0.04 |
Median | 0.28 | 0.74 | 0.05 | 0.11 | 0.2 | 0.5 | 0.03 | 0.05 |
IQR | 0.34 | 0.79 | 0.01 | 0.04 | 0.05 | 0.37 | 0.002 | 0.014 |
Wilcoxon’s signed rank test | 0.03 | 0.01 | 0.01 | 0.01 | 0.22 NS | 0.19 NS | 0.44 NS |
Patient | Tumor-to-kidney dose ratio | Tumor-to-stomach dose ratio | Tumor-to-bone marrow dose ratio | |||
---|---|---|---|---|---|---|
Entresto® | Without | With | Without | With | Without | With |
1 | n.a | n.a | n.a | n.a | n.a | n.a |
2 | n.a | n.a | n.a | n.a | n.a | n.a |
3 | n.a | n.a | n.a | n.a | n.a | n.a |
4 | 0.6 | 0.4 | 0.1 | 0.1 | 1.1 | 1 |
4a | 1.0 | 0.6 | 0.2 | 0.1 | 1.8 | 1.4 |
5 | n.a | n.a | n.a | n.a | n.a | n.a |
6 | 19.8 | 11.5 | 5.2 | 4.2 | 24.8 | 21.4 |
7 | 5.5 | 7.5 | 1.3 | 0.9 | 7.3 | 20.3 |
7a | 11.8 | 11.2 | 2.8 | 1.3 | 15.7 | 30.3 |
8 | 11.0 | 8.1 | 1.7 | 1.9 | 11 | 17.8 |
Median | 8.3 | 7.8 | 1.5 | 1.1 | 9.2 | 19.1 |
IQR | 9.5 | 8.1 | 2.1 | 1.5 | 11.4 | 15.7 |
Wilcoxon’s signed rank test |